Table I.
Clinical data of small lymphocytic lymphoma (SLL) patients (n = 12).
| Characteristics | Values |
|---|---|
| Sex | |
| Male | 7 (58·3%) |
| Female | 5 (41·7%) |
| Median age (years) | 69·0 |
| Median lymphocyte count/μl | 4020 |
| Median clonal lymphocyte count/μl | 928·5 |
| Median haemoglobin levels (g/l) | 142 |
| Median platelet count/μl | 225 000 |
| Matutes score ≥3 | 12 (100%) |
| IGHV unmutated | 7 (58·3%) |
| IGHV mutated | 5 (41·7%) |
| 17p deletion | 1 (8·3%) |
| No 17p deletion | 11 (91·7%) |
| 11q deletion | 2 (16·7%) |
| No 11q deletion | 10 (83·3%) |
| 13q deletion | 3 (25·0%) |
| No 13q deletion | 9 (75·0%) |
| Trisomy 12 | 2 (16·7%) |
| No Trisomy 12 | 10 (83·3%) |
| Treatment status | |
| Previously treated | 1 (8·3%) |
| Treatment‐naïve | 11 (91·7%) |
| First‐line treatment | |
| Watch and wait | 2 (16·7%) |
| Ibrutinib | 2 (16·7%) |
| Chemoimmunotherapy | 8 (66·7%) |
IGHV, immunoglobulin heavy chain gene.